Syphilis rates are climbing across the US, including in rural areas, while Native populations disproportionately bear the burden. Similarly, congenital syphilis has skyrocketed, disproportionately impacting Native-born infants. Meanwhile, the ongoing shortage of Bicillin L-A continues to hinder rapid treatment, and the need for effective solutions in rural and Native-serving clinics is critical.